Exagen Inc. (XGN)

NASDAQ: XGN · IEX Real-Time Price · USD
4.62
-0.02 (-0.43%)
May 24, 2022 4:00 PM EDT - Market closed

Ratios and Metrics (Annual)

Millions USD. Fiscal year is Jan - Dec.
YearCurrent202120202019
Market Capitalization
75188167319
Market Cap Growth
-12.56%-47.65%-
Enterprise Value
19116136273
PE Ratio
--7.00-10.01-10.54
PS Ratio
1.563.893.987.90
PB Ratio
0.992.213.995.73
EV/Sales Ratio
0.402.253.156.61
Debt / Equity Ratio
0.440.320.640.46
Debt / EBITDA Ratio
-1.26-1.19-1.95-3.26
Debt / FCF Ratio
-1.22-1.21-1.83-2.63
Current Ratio
8.7212.108.0413.78
Asset Turnover
0.380.370.520.69
Return on Equity (ROE)
-35.50%-28.70%-36.10%107.50%
Return on Assets (ROA)
-24.40%-20.60%-20.60%-51.70%
Return on Capital (ROIC)
-73.10%-69.50%-45.20%-30.10%
Earnings Yield
-41.16%-14.28%-9.99%-9.49%
FCF Yield
-37.04%-12.04%-8.71%-3.08%
Buyback Yield / Dilution
-31.28%-26.43%-252.99%-5580.14%
Total Shareholder Return
-31.28%-26.43%-252.99%-5580.14%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).